Whole-Genome mRNA Expression Profiling Identifies Functional and Prognostic Signatures in Patients with Mesenchymal Glioblastoma Multiforme.

CONCLUSIONS: The signatures were identified as risk predictors that patients who had a high-risk score tended to have unfavorable outcome, demonstrating their potential for personalizing cancer management.
PMID: 23663361 [PubMed - as supplied by publisher]

Source: CNS Neuroscience and Therapeutics - May 11, 2013 Category: Neuroscience Authors: Bao ZS, Zhang CB, Wang HJ, Yan W, Liu YW, Li MY, Zhang W Tags: CNS Neurosci Ther Source Type: research